These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 17204720)
1. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen. Kuehl H; Veit P; Rosenbaum SJ; Bockisch A; Antoch G J Nucl Med; 2007 Jan; 48 Suppl 1():45S-57S. PubMed ID: 17204720 [TBL] [Abstract][Full Text] [Related]
2. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging. Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616 [TBL] [Abstract][Full Text] [Related]
3. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339 [TBL] [Abstract][Full Text] [Related]
4. Imaging to optimally stage lung cancer: conventional modalities and PET/CT. Truong MT; Munden RF; Movsas B J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738 [TBL] [Abstract][Full Text] [Related]
5. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Schmidt GP; Kramer H; Reiser MF; Glaser C Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383 [TBL] [Abstract][Full Text] [Related]
6. PET/CT for the staging and follow-up of patients with malignancies. Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595 [TBL] [Abstract][Full Text] [Related]
7. Integrated PET/CT and cancer imaging. De Wever W; Coolen J; Verschakelen JA JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480 [TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases. D'souza MM; Sharma R; Mondal A; Jaimini A; Tripathi M; Saw SK; Singh D; Mishra A; Tripathi RP Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427 [TBL] [Abstract][Full Text] [Related]
11. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
12. Explicit incorporation of prior anatomical information into a nonrigid registration of thoracic and abdominal CT and 18-FDG whole-body emission PET images. Camara O; Delso G; Colliot O; Moreno-Ingelmo A; Bloch I IEEE Trans Med Imaging; 2007 Feb; 26(2):164-78. PubMed ID: 17304731 [TBL] [Abstract][Full Text] [Related]
13. Screening for cancer with PET and PET/CT: potential and limitations. Schöder H; Gönen M J Nucl Med; 2007 Jan; 48 Suppl 1():4S-18S. PubMed ID: 17204716 [TBL] [Abstract][Full Text] [Related]
14. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. Coleman RE; Delbeke D; Guiberteau MJ; Conti PS; Royal HD; Weinreb JC; Siegel BA; Federle MF; Townsend DW; Berland LL; ; ; J Nucl Med; 2005 Jul; 46(7):1225-39. PubMed ID: 16000293 [TBL] [Abstract][Full Text] [Related]
15. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI. Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103 [TBL] [Abstract][Full Text] [Related]
16. Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging. Kinner S; Antoch G; Bockisch A; Veit-Haibach P Abdom Imaging; 2007; 32(5):606-12. PubMed ID: 17387540 [TBL] [Abstract][Full Text] [Related]
17. Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice? Soyka JD; Veit-Haibach P; Strobel K; Breitenstein S; Tschopp A; Mende KA; Lago MP; Hany TF J Nucl Med; 2008 Mar; 49(3):354-61. PubMed ID: 18287263 [TBL] [Abstract][Full Text] [Related]
18. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721 [TBL] [Abstract][Full Text] [Related]
19. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection. Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]